Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-19

Clinical Trial Update: Imaging Tau in Alzheimer's Disease and Normal Aging [Phase 2]

View source ↗

Summary

Phase 2 clinical trial related to imaging tau in Alzheimer's disease and normal aging has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: William Charles Kreisl | Conditions: Alzheimer's Disease | Phase 2 | Status: TERMINATED | Results posted: 2018-11-19